ABN NEWSWIRE

Finance News

Anatara Lifesciences (ASX:ANR) CEO Steve Lydeamore is interviewed by ABN Newswire regarding the human trials and product pipeline.

11/19/2019 10:40:44 AM

Regeneus Ltd (ASX:RGS) Japanese Biotech Fund takes up all Rights Issue Shortfall

Regeneus Ltd (ASX:RGS), a clinical-stage regenerative medicine company, has placed the full shortfall of 9,437,872 shares under its recent Non-Renounceable Rights Issue. The shortfall was placed to a Japan-based institutional investor at an issue price of A$0.08 per share for a total of A$755,029.

11/19/2019 9:55:49 AM

Platina Resources Limited (ASX:PGM) Drilling Starts At Blue Moon Project

Platina Resources Limited (ASX:PGM)(OTCMKTS:PTNUF) has started drilling at its Blue Moon Project in the United States, a high-grade, zinc-copper rich massive sulphide with gold and silver precious metal credits.

11/19/2019 9:36:39 AM

Sayona Mining Ltd (ASX:SYA) Potential for New Lithium Deposit at Viau-Dallaire

Emerging lithium miner Sayona Mining Limited (ASX:SYA) (FRA:DML) (OTCMKTS:DMNXF) announced today an Exploration Target for the Viau-Dallaire prospect within the Company's Tansim Lithium Project in Quebec, Canada, highlighting the potential for the development of a new lithium deposit.